Brokerages Set Gain Therapeutics, Inc. (NASDAQ:GANX) PT at $8.20
Shares of Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) have been given an average recommendation of “Buy” by the six ratings firms that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price […]
Shares of Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) have been given an average recommendation of “Buy” by the six ratings firms that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price […]
